Should we integrate the gut microbiota composition to manage idiopathic nephrotic syndrome?
Nephrol Dial Transplant
.
2023 Aug 31;38(9):1927-1930.
doi: 10.1093/ndt/gfad126.
Authors
Maxime Espi
1
2
,
Christophe O Soulage
3
,
Laetitia Koppe
1
3
Affiliations
1
Centre International de recherche en Infectiologie, INSERM U1111, UCBL1, CNRS UMR5308, ENS, Lyon, France.
2
Department of Nephrology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
3
CarMeN lab, INSERM U1060, INRA, Université Claude Bernard Lyon 1, Villeurbanne, France.
PMID:
37365689
DOI:
10.1093/ndt/gfad126
No abstract available
Publication types
Editorial
Comment
MeSH terms
Child
Gastrointestinal Microbiome*
Glucocorticoids
Humans
Nephrosis, Lipoid*
Nephrotic Syndrome*
Recurrence
Syndrome
Substances
Glucocorticoids
Supplementary concepts
Nephrosis, congenital